Logo
x

Search

Subscribe Now

 Clinical Trial

GSK Provides Update on P-III (DREAMM-7) Trial of Blenrep for Treating R/R Multiple Myeloma

GSK Provides Update on P-III (DREAMM-7) Trial of Blenrep for Treating R/R Multiple Myeloma

  • November 14, 2024
Structure Therapeutics Reports the First Patient Dosing in P-IIb (ACCESS) Trial of GSBR-1290 for Obesity

Structure Therapeutics Reports the First Patient Dosing in P-IIb (ACCESS) Trial of GSBR-1290 for Obesity

  • November 14, 2024
Syros Pharmaceuticals Reports the P-III (SELECT-MDS-1) Study Data of Tamibarotene for Treating Myelodysplastic Syndrome

Syros Pharmaceuticals Reports the P-III (SELECT-MDS-1) Study Data of Tamibarotene for Treating Myelodysplastic Syndrome

  • November 13, 2024
AstraZeneca Provides Update on P-III (KOMET) Study of Koselugo for Treating Neurofibromatosis Type 1

AstraZeneca Provides Update on P-III (KOMET) Study of Koselugo for Treating Neurofibromatosis Type 1

  • November 12, 2024
Merck KGaA Reports Results from the P-III (MANEUVER) Study of Pimicotinib for Treating Tenosynovial Giant Cell Tumor (TGCT)

Merck KGaA Reports Results from the P-III (MANEUVER) Study of Pimicotinib for Treating Tenosynovial Giant Cell Tumor (TGCT)

  • November 12, 2024
AbbVie Reports the P-II (EMPOWER) Studies Data of Emraclidine for Treating Schizophrenia

AbbVie Reports the P-II (EMPOWER) Studies Data of Emraclidine for Treating Schizophrenia

  • November 12, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.